Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-04 09:12 am Sale | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | WELLINGTON MANAGEMENT GROUP LLP | 5,148,566 9.480% | -2,728,804 (-34.64%) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BlackRock Inc. BLK | 5,408,536 9.950% | -523,124 (-8.82%) | Filing History |
| 2022-01-19 12:37 pm Purchase | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | JPMORGAN CHASE & CO JPM | 3,099,569 5.700% | 3,099,569 (New Position) | Filing History |
| 2021-12-09 1:54 pm Sale | 2021-11-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | The Vanguard Group | 5,484,574 10.100% | -141,139 (-2.51%) | Filing History |
| 2021-08-09 3:23 pm Purchase | 2021-07-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BlackRock Inc. BLK | 5,931,660 10.100% | 1,446,660 (+32.26%) | Filing History |
| 2021-04-05 5:26 pm Unchanged | 2021-04-05 | 13D | Agios Pharmaceuticals, Inc. AGIO | BRISTOL MYERS SQUIBB CO BMY | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-03-10 09:46 am Purchase | 2021-03-09 | 13G | Agios Pharmaceuticals, Inc. AGIO | FMR LLC | 7,633,980 10.968% | 3,295,314 (+75.95%) | Filing History |